Global Longlife Hospital and Research Ltd
Global Longlife Hospital and Research Ltd (GLHRL) last reported results for the quarter ended Mar 2026, with sales of ₹0 crore and net profit of ₹-0.4 crore. The next scheduled event is an EGM on 30 Oct 2026. The stock last traded at ₹11.8, a market capitalisation of ₹12.3 crore. Over the past 52 weeks the stock has ranged between ₹9 and ₹25.8. Figures are as of 6 Oct 2026 and are not real time.
Global Longlife Hospital and Research Ltd share price and key metrics
- Current price
- ₹11.8
- Market cap
- ₹12.3 cr
- Book value
- ₹22.6
- ROE
- -6.81%
- ROCE
- -3.92%
- Dividend yield
- 0.00%
- 52w high / low
- 25.8/9.00
Metrics as of 6 Oct 2026. Not real time.
Track Global Longlife Hospital and Research Ltd
Cruxal reads every Global Longlife Hospital and Research Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Global Longlife Hospital and Research Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -100%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 63%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- -34%
- 1 Year
- -50%
- 10 Years
- %
- 5 Years
- -2%
- 3 Years
- -9%
- Last Year
- -7%
Global Longlife Hospital and Research Ltd quarterly results
| ₹ crore | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 11.8 | 11.7 | 12.33 | 1.18 | 0.58 | 0 | 0 | 0 |
| Expenses | 10.03 | 9.44 | 9.62 | 4.2 | 4.39 | 0.35 | 0.6 | 0.4 |
| Operating profit | 1.77 | 2.26 | 2.71 | -3.02 | -3.81 | -0.35 | -0.6 | -0.4 |
| OPM % | 15.00% | 19.32% | 21.98% | -255.93% | -656.90% | — | — | — |
| Other income | 0.07 | 0.17 | 0.02 | 0.04 | 5.69 | -0.67 | 0.01 | 0 |
| Interest | 0.2 | 0.2 | 0.41 | 0.36 | 0.28 | 0 | 0 | 0 |
| Depreciation | 0.58 | 0.59 | 0.61 | 0.64 | 0.48 | 0 | 0 | 0 |
| Profit before tax | 1.06 | 1.64 | 1.71 | -3.98 | 1.12 | -1.02 | -0.59 | -0.4 |
| Tax % | 29.25% | 35.37% | 39.77% | -19.10% | -11.61% | 2.94% | 123.73% | 0.00% |
| Net profit | 0.76 | 1.07 | 1.03 | -3.22 | 1.24 | -1.04 | -1.32 | -0.4 |
| EPS (₹) | 0.72 | 1.02 | 0.98 | -3.07 | 1.18 | -0.99 | -1.26 | -0.38 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Global Longlife Hospital and Research Ltd annual results
| ₹ crore | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 33.44 | 33.32 | 32.7 | 32.44 | 23.38 | 13.46 | 0.31 | 0 |
| Operating profit | 6.83 | 3.44 | 5.44 | 8.3 | 4.08 | -0.22 | -4.14 | -1 |
| OPM % | 20.42% | 10.32% | 16.64% | 25.59% | 17.45% | -1.63% | -1,335.48% | — |
| Net profit | 1.36 | -0.86 | 2.05 | 3.57 | 1.83 | -2.19 | 0.2 | -1.72 |
| EPS (₹) | 1.94 | -1.23 | 2.93 | 5.10 | 1.74 | -2.09 | 0.19 | -1.64 |
TTM is the trailing twelve months to the most recent quarter.
Global Longlife Hospital and Research Ltd balance sheet
| ₹ crore | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 7.00 | 7.00 | 7.00 | 7.00 | 10.50 | 10.50 | 10.50 | 10.50 |
| Reserves | 5.35 | 4.49 | 6.68 | 9.96 | 53.79 | 15.43 | 16.29 | 13.25 |
| Borrowings | 27.18 | 23.51 | 17.04 | 8.69 | 9.29 | 12.74 | 0.00 | 0.00 |
| Other liabilities | 3.77 | 6.92 | 6.06 | 8.33 | 2.36 | 3.07 | 0.06 | 0.01 |
| Total liabilities | 43.30 | 41.92 | 36.78 | 33.98 | 75.94 | 41.74 | 26.85 | 23.76 |
| Fixed assets | 20.17 | 18.72 | 17.46 | 16.71 | 16.52 | 17.27 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 1.03 | 0.00 | 0.00 | 0.00 |
| Investments | 0.10 | 0.10 | 0.47 | 0.10 | 0.10 | 0.03 | 0.03 | 0.00 |
| Other assets | 23.03 | 23.10 | 18.85 | 17.17 | 58.29 | 24.44 | 26.82 | 23.76 |
| Total assets | 43.30 | 41.92 | 36.78 | 33.98 | 75.94 | 41.74 | 26.85 | 23.76 |
As reported by the company. Total assets equal total liabilities by construction.
Global Longlife Hospital and Research Ltd cash flow
| ₹ crore | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 5.40 | 3.90 | 6.88 | 9.42 | -40.42 | -5.07 | 12.32 | -4.51 |
| Cash from investing | -0.33 | -0.04 | 0.02 | 0.01 | -1.90 | -0.82 | 21.80 | 0.04 |
| Cash from financing | -4.77 | -3.05 | -7.22 | -9.66 | 45.70 | 2.67 | -13.01 | 0.00 |
| Net cash flow | 0.31 | 0.81 | -0.33 | -0.22 | 3.38 | -3.22 | 21.11 | -4.47 |
| Free cash flow | 5.00 | 3.79 | 6.84 | 8.96 | -42.42 | -6.10 | 33.42 | -4.51 |
| CFO / operating profit | 79% | 113% | 126% | 105% | -960% | 2,259% | -304% | 401% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Global Longlife Hospital and Research Ltd operating ratios
| Per year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | — | 3.81% | 12.75% | 26.22% | 6.35% | -2.51% | -13.69% | -3.92% |
| Debtor days | 94.85 | 68.68 | 87.51 | 100.25 | 151.43 | 52.88 | 376.77 | — |
| Inventory days | 169.49 | 157.97 | 34.46 | 88.98 | 69.12 | 131.64 | 0.00 | — |
| Days payable | 229.91 | 391.69 | 138.68 | 432.74 | 110.43 | 765.90 | — | — |
| Cash conversion cycle | 34.44 | -165.03 | -16.71 | -243.52 | 110.13 | -581.38 | 376.77 | — |
| Working capital days | 19.21 | 12.16 | 7.14 | -29.70 | 344.86 | -238.36 | 1,283.39 | — |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Global Longlife Hospital and Research Ltd shareholding pattern
Promoters held 22.88% at Jun 2026, down from 54.90% at Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 54.29% | 54.29% | 54.29% | 54.90% | 55.10% | 35.44% | 22.88% | 22.88% |
| Public | 45.73% | 45.72% | 45.70% | 45.10% | 44.91% | 64.56% | 77.11% | 77.12% |
| No. of shareholders | 974 | 989 | 938 | 917 | 915 | 985 | 1,149 | 1,133 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Global Longlife Hospital and Research Ltd events
The next scheduled event is an EGM on 30 Oct 2026.
- EGMApproval of issuance at the Extra-Ordinary General Meeting
- Record dateFirst Extra Ordinary General Meeting and E-voting
- AGMApproval of change of company name from 'Global Longlife Hospital and Research Limited' to 'Asahi Enterprise Limited'
See the full results calendar for every Indian company reporting in the next 30 days.
Global Longlife Hospital and Research Ltd corporate filings
- Publication of Newspaper Advertisement for First EGM and E-Voting Notice by Global Longlife Hospital and Research LtdCompany Updatelow impact
Cruxal's analysis: The company announced the publication of a newspaper advertisement regarding its upcoming…
Read the full analysis - Regulatory Approval and Certification Confirmed for Name Change to 'Asahi Enterprise Limited' with Compliance Certification from CAAGM/EGMhigh impact
Cruxal's analysis: The company, formerly known as Global Longlife Hospital and Research Limited, has…
Read the full analysis - Asahi Enterprise Limited Approves EGM to Raise Capital; Financial Impact PendingOthersmedium impact
Cruxal's analysis: Asahi Enterprise Limited has announced the approval of an Extraordinary General Meeting…
Read the full analysis - Intimation of Closure of Trading Window.Insider Trading / SASTlow impact
- Global Longlife Hospital and Research Ltd receives ROC approval for name changeCompany Updatelow impact
Cruxal's analysis: The company has received approval from the Registrar of Companies for an alteration in…
Read the full analysis - Abhishek Ashvinbhai Kamdar HUF acquires 5.09% stake in Global Longlife Hospital and Research Ltd via open marketInsider Trading / SASThigh impact
Cruxal's analysis: Abhishek Ashvinbhai Kamdar HUF has disclosed the acquisition of 5,35,000 equity shares of…
Read the full analysis - Global Longlife Hospital and Research Ltd announces alteration to Memorandum of Association objects clauseCompany Updatelow impact
Cruxal's analysis: The company has initiated a process to alter the objects clause of its Memorandum of…
Read the full analysis - Trade Pulse Broking Private Limited Increases Stake in Global Longlife Hospital and Research Ltd to 7.31%Insider Trading / SASTmedium impact
Cruxal's analysis: Trade Pulse Broking Private Limited has acquired an additional 2 lakh 68 thousand shares…
Read the full analysis - Promoter Dhruv Sureshkumar Jani Divests 6.88% Stake in Global Longlife Hospital and Research Limited via Open MarketInsider Trading / SASTmedium impact
Cruxal's analysis: Global Longlife Hospital and Research Limited promoter Dhruv Sureshkumar Jani has…
Read the full analysis - Promoter Dhruv Sureshkumar Jani Divests 9.52% Stake in Global Longlife Hospital and Research Limited via Open MarketInsider Trading / SASTmedium impact
Cruxal's analysis: Global Longlife Hospital and Research Limited promoter Dhruv Sureshkumar Jani has…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.